Search
Search Constraints
Start Over You searched for: Subjects Therapeutic Equivalency ✖Remove constraint Subjects: Therapeutic EquivalencyRefine by:
- ANDA submissions: amendments and requests for final approval to tentatively approved ANDAs1
- Competitive generic therapies: guidance for industry1
- Compliance policy for the quantity of bioavailability and bioequivalence samples retained under 21 CFR 320.38(c)1
- Determining whether to submit an ANDA or a 505(b)(2) application1
- Examining two approaches to U.S. drug pricing: international prices and therapeutic equivalency1
- English14
- 1000 to 1099 0
- 1100 to 1199 0
- 1200 to 1299 0
- 1300 to 1399 0
- 1400 to 1499 0
- 1500 to 1599 0
- 1600 to 1699 0
- 1700 to 1799 0
- 1800 to 1899 0
- 1900 to 1999 1
- 2000 to 2024 13
Current results range from 1990 to 2022